The changing landscape in the management of newly diagnosed castration sensitive metastatic prostate cancer

by Daniel C. Parker, Michael S. Cookson
Published 2020-02-01

Urothelial Carcinoma of the Bladder Metastatic to Bone Marrow Presenting as Isolated Thrombocytopenia

by Robert C. Chan, Greg L. Hundemer, Amy Tatsas, Michael S. Cookson
Published 2007-01-01

Use of intravesical valrubicin in clinical practice for treatment of nonmuscle-invasive bladder cancer, including carcinoma of the bladder

by Michael S. Cookson, Sam S. Chang, Christine Lihou, Thomas Li, Samira Q. Harper, Zhihui Lang, Ronald F. Tutrone
Published 2014-10-01

8q24 genetic variation and comprehensive haplotypes altering familial risk of prostate cancer

by William D. Dupont, Joan P. Breyer, W. Dale Plummer, Sam S. Chang, Michael S. Cookson, Joseph A. Smith, University of Washington Center for Mendelian Genomics, Elizabeth E. Blue, Michael J. Bamshad, Jeffrey R. Smith
Published 2020-03-01

Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation.

by David J DeGraff, Peter E Clark, Justin M Cates, Hironobu Yamashita, Victoria L Robinson, Xiuping Yu, Mark E Smolkin, Sam S Chang, Michael S Cookson, Mary K Herrick, Shahrokh F Shariat, Gary D Steinberg, Henry F Frierson, Xue-Ru Wu, Dan Theodorescu, Robert J Matusik
Published 2012-01-01